EXCLUSIVE: David Lenigas answers investor questions on Weald Basin, Cuba, medicinal cannabis

David Lenigas answers all your investor questions in a long and frank interview with London South East.

Lenigas says AfriAg wants ‘global domination’ of the medicinal cannabis industry after Trump’s sanctions killed the Cuban strategy. LGC have purchased a share stake in cannabis-licenced ‘Little Green Pharma’. Durban and Zimbabwe are two of the best growing locations in the world. LGC are currently rolling out a global buy and build strategy.

David tells us he remains a shareholder in UKOG, that UKOG brought oil to the surface for the first time yesterday afternoon, that Angus Energy’s Brokenham is ‘multiple times better than Horse Hill’, that ‘overall the Weald has potential for 128 billion barrels of oil’.

David talks about Professor David Smythe, describes the AIM market as ‘toxic’ and the AIM markets makers as ‘manipulating the market in a way not found elsewhere’.

David is now co-Chair of LGC Capitol, listed on TSX, Chairman of NEX-listed AfriAg Global, Chair of ASX-listed Doriemus and Artemis.

Malcare WordPress Security